Brought to you by 
Luminex acquires GenturaDx for $50mm in cash plus earn-outs
Jul 2012
Executive Summary
Biological testing company Luminex Corp. is paying $50mm in cash to acquire privately held GenturaDx (automated nucleic acid purification), which will become a wholly owned subsidiary.
Deal Industry
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Medical Devices
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Payment Includes Cash
- Full Acquisition
- Includes Contract
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Luminex acquires GenturaDx for $50mm in cash plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice